Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages ; volume:15 ; number:1 ; day:18 ; month:11 ; year:2014 ; pages:1-13 ; date:12.2014
BMC genomics ; 15, Heft 1 (18.11.2014), 1-13, 12.2014
- Creator
-
Kaushik, Swati
- Contributor
-
Sowdhamini, Ramanathan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-15-985
- URN
-
urn:nbn:de:1111-2016072857264
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kaushik, Swati
- Sowdhamini, Ramanathan
- SpringerLink (Online service)
Other Objects (12)
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Modeling of motion primitive architectures using domain-specific languages
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Modeling of motion primitive architectures using domain-specific languages
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors